1. Assessment of nanomaterial-induced hepatotoxicity using a 3D human primary multi-cellular microtissue exposed repeatedly over 21 days - the suitability of the in vitro system as an in vivo surrogate
- Author
-
Ulla Vogel, Wolfgang Moritz, Graeme Whyte, Ali Kermanizadeh, Vicki Stone, Trine Berthing, Ewa Guzniczak, and Melanie Wheeldon
- Subjects
3D primary human multi-cellular liver microtissue ,Cell Survival ,Kupffer Cells ,In vitro hepatotoxicology ,Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,Cell ,lcsh:Industrial hygiene. Industrial welfare ,02 engineering and technology ,Pharmacology ,Toxicology ,Tissue Culture Techniques ,03 medical and health sciences ,Liver Function Tests ,lcsh:RA1190-1270 ,In vivo ,RA1190-1270 ,Albumins ,medicine ,Humans ,Cytotoxicity ,lcsh:Toxicology. Poisons ,030304 developmental biology ,In vitro vs. in vivo comparisons ,0303 health sciences ,Chemistry ,Research ,General Medicine ,HD7260-7780.8 ,021001 nanoscience & nanotechnology ,Coculture Techniques ,In vitro ,Nanostructures ,medicine.anatomical_structure ,Cytokine ,Liver ,Nanotoxicology ,Cell culture ,Toxicology. Poisons ,Hepatocytes ,Cytokines ,Industrial hygiene. Industrial welfare ,Chemical and Drug Induced Liver Injury ,0210 nano-technology ,lcsh:HD7260-7780.8 ,Ex vivo - Abstract
Background With ever-increasing exposure to engineered nanomaterials (NMs), there is an urgent need to evaluate the probability of consequential adverse effects. The potential for NM translocation to distal organs is a realistic prospect, with the liver being one of the most important target organs. Traditional in vitro or ex vivo hepatic toxicology models are often limiting (i.e. short life-span, reduced metabolic activity, lacking important cell populations, etc.). In this study, we scrutinize a 3D human liver microtissue (MT) model (composed of primary hepatocytes and non-parenchymal cells). This unique experiment benefits from long-term (3 weeks) repeated very low exposure concentrations, as well as incorporation of recovery periods (up to 2 weeks), in an attempt to account for the liver’s recovery capacity in vivo. As a means of assessing the toxicological potential of NMs, cell cytotoxicity (cell membrane integrity and aspartate aminotransferase (AST) activity), pro/anti-inflammatory response and hepatic function were investigated. Results The data showed that 2 weeks of cell culture might be close to limits before subtle ageing effects start to overshadow low sub-lethal NM-induced cellular responses in this test system (adenylate kinase (AK) cytotoxicity assay). We showed that in vitro AST measurement are not suitable in a nanotoxicological context. Moreover, the cytokine analysis (IL6, IL8, IL10 and TNF-α) proved useful in highlighting recovery periods as being sufficient for allowing a reduction in the pro-inflammatory response. Next, low soluble NM-treated MT showed a concentration-dependent penetration of materials deep into the tissue. Conclusion In this study the advantages and pitfalls of the multi-cellular primary liver MT are discussed. Furthermore, we explore a number of important considerations for allowing more meaningful in vitro vs. in vivo comparisons in the field of hepatic nanotoxicology.
- Published
- 2019
- Full Text
- View/download PDF